Pharmacoeconomic analyses - Making them transparent, making them credible

被引：75

作者：

Rennie, D

Luft, HS

机构：

[1] JAMA, Chicago, IL 60610 USA

[2] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2000年 / 283卷 / 16期

关键词：

D O I：

10.1001/jama.283.16.2158

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2158 / 2160

页数：3

共 28 条

[1] Disclosure of authors' conflicts of interest: A follow-up. [J].

Angell, M ;

Utiger, RD ;

Wood, AJJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08) :586-587

[2] Improving the quality of reporting of randomized controlled trials - The CONSORT statement [J].

Begg, C ;

Cho, M ;

Eastwood, S ;

Horton, R ;

Moher, D ;

Olkin, I ;

Pitkin, R ;

Rennie, D ;

Schulz, KF ;

Simel, D ;

Stroup, DF .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08) :637-639

[3] Influences on the quality of published drug studies [J].

Bero, LA ;

Rennie, D .

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1996, 12 (02) :209-237

[4] THE PUBLICATION OF SPONSORED SYMPOSIUMS IN MEDICAL JOURNALS [J].

BERO, LA ;

GALBRAITH, A ;

RENNIE, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (16) :1135-1140

[5] Guidelines for authors and peer reviewers of economic submissions to the BMJ [J].

Drummond, MF ;

Jefferson, TO .

BRITISH MEDICAL JOURNAL, 1996, 313 (7052) :275-283

[6] MANUFACTURING CONSENSUS, MARKETING TRUTH - GUIDELINES FOR ECONOMIC-EVALUATION [J].

EVANS, RG .

ANNALS OF INTERNAL MEDICINE, 1995, 123 (01) :59-60

[7] Evaluation of conflict of interest in economic analyses of new drugs used in oncology [J].

Friedberg, M ;

Saffran, B ;

Stinson, TJ ;

Nelson, W ;

Bennett, CL .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (15) :1453-1457

[8]

Gagnon JP, 2000, JAMA-J AM MED ASSOC, V283, P1423, DOI 10.1001/jama.283.11.1423

[9] Problems with the interpretation of pharmacoeconomic analyses - A review of submissions to the Australian pharmaceutical benefits scheme [J].

Hill, SR ;

Mitchell, AS ;

Henry, DA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (16) :2116-2121

[10] AVOIDING BIAS IN THE CONDUCT AND REPORTING OF COST-EFFECTIVENESS RESEARCH SPONSORED BY PHARMACEUTICAL COMPANIES [J].

HILLMAN, AL ;

EISENBERG, JM ;

PAULY, MV ;

BLOOM, BS ;

GLICK, H ;

KINOSIAN, B ;

SCHWARTZ, JS .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (19) :1362-1365

← 1 2 3 →